The impact of reduced dosing frequency of elranatamab on patient‐reported outcomes in patients with relapsed or refractory multiple myeloma: Results from MagnetisMM‐3
作者
Nizar J. Bahlis,Ajay K. Nooka,Marco DiBonaventura,Sharon T. Sullivan,Mohammad A. Chaudhary,Didem Aydin,Mohamad Mohty